Carregant...
775. Comparison of Initial Vancomycin Costs and Target Attainment Between Trough- and 24-Hour Area Under the Concentration–Time Curve (AUC24)-Guided Dosing
BACKGROUND: Vancomycin is the treatment-of-choice for most invasive methicillin-resistant Staphylococcus aureus (MRSA) infections. Although serum trough concentration-guided vancomycin dosing is the current standard, dosing based on AUC(24) to minimum inhibitory concentration ratio best predicts eff...
Guardat en:
| Publicat a: | Open Forum Infect Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811313/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.843 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|